Attomarker Ltd products

Attomarker has developed a technology platform that will measure the concentration of biomarkers in blood samples, but it can be readily extended to saliva or even cerebral spinal fluid. The blood contains many components – biomarkers – that have normal levels during good health and change when you get sick. But this needs to be personal – so what is normal for you when you are healthy. The idea is to measure many biomarkers at once so a profile can be obtained pointing to a greater understanding of the evolving good health or disease. The burden of taking blood currently is quite high and Attomarker can take a small volume, 10 µL, measure 20 biomarkers and give the results in 7 minutes. What started as a research grant is now a reality and on sale in three countries.